DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 1Pharmathen SA
03 2Hebei AiYoung Pharmaceutical Technology
04 5Accord healthcare
05 1Activo Health
06 1Akorn Pharmaceuticals
07 1Altan Pharma
08 1Aurobindo Pharma Limited
09 1Austell Laboratories
10 2Avet Pharmaceuticals
11 2Avyxa
12 1Baxter Healthcare Corporation
13 1Biem Ilac San. ve Tic. A.S
14 2Biomab Innovation (Pty) Ltd
15 1Chartwell Pharmaceuticals llc
16 1Cipla
17 2Dr Reddy's Laboratories (Australia) Pty Ltd
18 4Farbe Firma
19 1Farmatek
20 4Fresenius Kabi AB Brunna
21 3Fresenius Kabi USA
22 1Fresenius SE & Co. KGaA
23 2Hangzhou Jiuyuan Gene Engineering
24 18Helsinn Advanced Synthesis
25 5Helsinn Birex Pharmaceuticals Lt
26 1Hetero Drugs
27 1Hikma Pharmaceuticals
28 2Hospira, Inc.
29 1Jiangsu Hengrui Medicine
30 1Kalcex
31 2Knight Therapeutics
32 1LABORATORIO REIG JOFRE SA
33 1MEDOCHEMIE LTD
34 1Macleods Pharmaceuticals Limited
35 1Macure Pharma
36 2Medsurge Healthcare
37 1Meitheal Pharmaceuticals
38 1Novast Laboratories
39 1ORIFARM GROUP AS
40 1Pharmada Pharmaceuticals
41 1Polifarma
42 4Qilu Pharmaceutical
43 1Reig Jofre
44 1STADA Arzneimittel
45 2Sagent Pharmaceuticals
46 3Samyang Biopharmaceuticals
47 1Sandoz B2B
48 1Tecnimede
49 3Teva Pharmaceutical Industries
50 2Themis Medicare
51 2TherDose Pharma
52 1Viatris
53 1Yangtze River Pharmaceutical Group
01 1CAPSULE
02 2CAPSULE;ORAL
03 5Capsule
04 1Capsules
05 2Concentrate For Solution For Infusion
06 2Hard Capsule
07 1Hard Capsules
08 8INJ
09 1INJECTABLE;INJECTION
10 25INJECTABLE;INTRAVENOUS
11 1IV Injection Solution
12 2Injectable
13 9Injectable Solution
14 1Injectable Solution In Pre-Filled Syringe
15 14Injection
16 6Injection Solution
17 3Liquid Injection
18 1Netupitant+Palonosetron 0,5+300Mg 1 Combined Oral Use
19 1POWDER;INTRAVENOUS
20 1Palonosetron 250Mcg 5Ml 1 Units Parenteral Use
21 3Powder For Concentrate For Solution For Infusion
22 1SOLUTION
23 5SOLUTION;INTRAVENOUS
24 1Soft Capsule
25 4Solution For Injection
26 1Solution for I.V. Injection
27 1Solution for IV Injection
28 1Solution for Injection
29 4Blank
01 3Approved
02 8Authorized
03 3Cancelled
04 14DISCN
05 7Generic
06 5Marketed
07 3Not Marketed
08 2Originator
09 2PRESCRIPTION
10 10Prescription
11 19RX
12 1USA
13 31Blank
01 4AKYNZEO
02 4ALOXI
03 12Akynzeo
04 7Aloxi
05 1Bevativa
06 1Ferant
07 1Hetnoset
08 1Kemoprev IV
09 1Onicit
10 2PALIBOUT
11 3PALONOSETRON
12 1PALONOSETRON 0.05mg/ml FRESENIUS
13 1PALONOSETRON 0.25 TEVA
14 26PALONOSETRON HYDROCHLORIDE
15 2PALONOSETRON Medsurge
16 2POSFREA
17 1Palcita
18 2Palonosetron
19 2Palonosetron Accord
20 1Palonosetron Altan
21 2Palonosetron Dr.Reddy's
22 4Palonosetron Fresenius Kabi
23 2Palonosetron Hydrochloride
24 1Palonosetron Kalceks
25 1Palonosetron Qilu
26 1Palonosetron Sala
27 1Palonosetron "Accord"
28 1Palonosetron "Macure"
29 1Palonosetron "Reig Jofre"
30 1Palonosetron "Stada"
31 1Palonosetronhydrochlorid "Qilu"
32 1Paloxitron
33 1Palton
34 1Themiset 250
35 1Themiset 75
36 1Votron
37 12Blank
01 4Australia
02 2Canada
03 6China
04 10Denmark
05 1Greece
06 10India
07 2Italy
08 8Norway
09 1Portugal
10 9South Africa
11 3South Korea
12 11Spain
13 3Sweden
14 4Turkey
15 34USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : DISCN
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 300; 0.5
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Hebei AiYoung Pharmaceutical Technology delivering high-quality APIs, intermediates, and end-to-end pharma solutions globally.
Regulatory Info :
Registration Country : China
Brand Name : Palonosetron Hydrochloride
Dosage Form : Injection
Dosage Strength : 1.5ML/0.075MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Palonosetron
Dosage Form : Injectable
Dosage Strength : 0.075 mg / 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Palonosetron
Dosage Form : Injectable
Dosage Strength : 0.25 mg / 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Hebei AiYoung Pharmaceutical Technology delivering high-quality APIs, intermediates, and end-to-end pharma solutions globally.
Regulatory Info :
Registration Country : China
Brand Name : Palonosetron Hydrochloride
Dosage Form : Injection
Dosage Strength : 5ML/0.25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-03-15
Application Number : 204615
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-11-06
Application Number : 204702
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-07-25
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-29
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-08-22
Application Number : 22233
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 204289
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2015-10-13
Application Number : 202521
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : DISCN
Registration Country : USA
